Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

FDA lifts partial clinical hold on phase Ib study of RVU-120 in AML and MDS

July 15, 2021

Antibiotics double as antitumor kinase inhibitors

July 15, 2021

Enrollment begins in phase I study of BI-1810631 in advanced solid tumors

July 15, 2021

New G12C mutant GTPase KRAS inhibitors presented by Novartis

July 15, 2021

Merck & Co. discovers protein arginine N-methyltransferase 5 inhibitors

July 15, 2021

Mutant EGFR inhibitors identified at Roche

July 15, 2021

Oral fadraciclib enters phase I/II study in advanced solid tumors

July 14, 2021

Barcoding strategy tracks breast cancer metastases

July 14, 2021

SFX-01 shown to be effective in in vitro models of blood cancers

July 14, 2021

Janssen Pharmaceutica discovers menin/MLL interaction inhibitors

July 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...